Comparative analysis of the clinical efficacy of conservative treatment for adenomyosis using traditional Chinese medicine and Western medicine

Table 3 Serum markers

Time	Group A (n = 70)	Group B (n = 70)	Group C (n = 70)	F _time /P _time value	F _interaction/P _interaction value	F _treatment/P _treatment value
Pre-treatment ^a	350.01 ± 30.07	342.91 ± 33.88	352.42 ± 33.66	5116.507 /<0.001	3.243 /0.012	5.082 /0.007
3 months of treatment ^b	217.33 ± 26.20	200.93 ± 21.02	212.51 ± 29.27
6 months of treatment ^b	104.23 ± 13.02	105.02 ± 11.69	99.94 ± 11.30
Pre-treatment ^a	9.60 ± 1.22	9.34 ± 1.19	9.21 ± 1.20	2752.047 /<0.001	3.377 /0.014	7.375 /0.001
3 months of treatment ^b	6.13 ± 0.66	6.53 ± 0.67	5.86 ± 0.72
6 months of treatment ^a	2.97 ± 0.78	3.04 ± 0.69	2.90 ± 0.46
Pre-treatment ^a	125.87 ± 32.42	114.23 ± 22.30	122.51 ± 24.21	1668.382 /<0.001	2.150 /0.105	6.113 /0.003
3 months of treatment ^b	40.37 ± 10.89	36.35 ± 9.08	35.85 ± 8.82
6 months of treatment ^a	38.35 ± 6.58	36.76 ± 8.34	36.96 ± 8.93

Note: E2: Estradiol; FSH: Follicle stimulating hormone; CA125: Carbohydrate antigen 125; a: Without significant differences between groups; b: With significant difference between groups

ISSN: 2072-1315